Diseases, Conditions, Syndromes

Researchers apply new immune technologies in search of mono vaccine

A research lab at the University of Kansas School of Engineering and School of Pharmacy is analyzing the genetics of human immune responses to develop the basis of an effective vaccine or drug therapy against Epstein-Barr ...

Diseases, Conditions, Syndromes

Multiple sclerosis: Myelin may be detrimental to nerve fibers

Multiple sclerosis (MS) affects millions of people worldwide, and there is currently no cure for this disease of the central nervous system. Damage to the nerve fibers, also called axons, is responsible for the severity of ...

HIV & AIDS

Individual genotype influences effectiveness of HIV vaccine

Almost 40 million people worldwide live with HIV/AIDS. Despite great effort, HIV-1 vaccine development has been challenging. A recent HIV vaccine trial, known as RV144, revealed that a combination of 2 vaccines protected ...

Diseases, Conditions, Syndromes

COVID comeback seen in parts of US as funding runs dry

COVID is making its latest comeback in parts of the northeastern United States as the BA.2 coronavirus variant becomes dominant in the country, officials said Wednesday, while urging Congress to pass new funding or risk the ...

Diseases, Conditions, Syndromes

Ebola vaccine promising in first human trials

Researchers say they're a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

Immunology

The eye is not immune to immunity

A person needs immune-suppressive drugs for organ transplants but not typically for transplants in the eye. How come? Like a few other parts of the body, some components of the eye, like the lens, don't have direct access ...

page 5 from 10